{"schema_version":"1","generated_at":"2026-10-30T01:38:59.467Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/susan-bates","json_url":"https://www.findmykol.com/kol/susan-bates/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"susan-bates","name":"Susan Bates","credential":"MD","title":"Professor of Medicine at CUMC; Director, Translational Cancer Medicine","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Breast","therapeutic_areas":["Breast","Lung","Genitourinary","Lymphoma","Gynecologic"],"institution":"NewYork-Presbyterian","institution_url":"https://www.findmykol.com/institution/weill-cornell-medicine","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1508080029"},"summary":"Susan Bates is Professor of Medicine at CUMC; Director, Translational Cancer Medicine at NewYork-Presbyterian. ClinicalTrials.gov lists 14 registered studies with this person as an investigator.","overview":{"text":"Susan E. Bates, M.D., is Professor of Medicine at CUMC at NewYork-Presbyterian / Columbia University Irving Medical Center. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 4 companies.","bullets":["Top research focus: Breast Cancer","14 registered trials on ClinicalTrials.gov","Open Payments reporting from 4 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":6,"topics":0,"strength":18},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Uterine Cervical Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Kidney Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Breast Cancer","Lung Cancer (NSCLC/SCLC)","Brain Neoplasms","Kidney Neoplasms","Lymphoma","Neoplasm Metastasis","Ovarian / Gynecologic Cancer","Uterine Cervical Neoplasms"],"drugs_studied":{"total":8,"shown":3,"withheld":5,"rows":[{"name":"Onivyde","generic":"Irinotecan","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Capmatinib","trials":1,"payments":0,"publications":0,"mentions":1},{"name":"Lanreotide","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":10,"shown":3,"withheld":7,"rows":[{"name":"National Cancer Institute (NCI)","trials":6,"payments":0,"mentions":6},{"name":"Daiichi Sankyo Inc.","trials":0,"payments":3,"mentions":3},{"name":"Ipsen Biopharmaceuticals, Inc","trials":0,"payments":3,"mentions":3}]}},"scholarship":{"h_index":0,"pubmed_count":0,"latest_activity_year":2025,"source":"works"},"trials":{"count":14,"shown":3,"withheld":11,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06616584","title":"Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)","phase":"PHASE2/PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT06616584","trial_url":"https://www.findmykol.com/trial/NCT06616584"},{"nct":"NCT06498635","title":"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT06498635","trial_url":"https://www.findmykol.com/trial/NCT06498635"},{"nct":"NCT05642572","title":"Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT05642572","trial_url":"https://www.findmykol.com/trial/NCT05642572"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2022,"last":2025},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"BeiGene USA, Inc.","program_year":2025,"amount_usd":19.86,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1508080029"},{"payer":"Daiichi Sankyo Inc.","program_year":2024,"amount_usd":828.73,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1508080029"},{"payer":"Ipsen Biopharmaceuticals, Inc","program_year":2023,"amount_usd":21.7,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1508080029"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1508080029","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":2,"classes":[{"class":"Salt solutions","setting":"prescribed","share_pct":72.5,"drugs":[{"name":"Sodium Chloride","share_pct":100}],"max_beneficiaries":null},{"class":"Low Molecular Weight Heparin","setting":"prescribed","share_pct":27.5,"drugs":[{"name":"Enoxaparin Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2020,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":60,"shown":3,"withheld":57,"rows":[{"project":"U2FFD008096","title":"Mississippi State Department of Health MFRPS Flexible Funding Model-Infrastructure Maintenance Grant Application","fiscal_year":2023,"amount_usd":150000,"organization":"MISSISSIPPI STATE DEPARTMENT OF HEALTH","source_url":"https://reporter.nih.gov/quickSearch/U2FFD008096"},{"project":"U18FD006418","title":"Mississippi State Department of Health , MFRPS, and RRT Flexible Funding Model Maintenance Grant Application","fiscal_year":2022,"amount_usd":150000,"organization":"MISSISSIPPI STATE DEPARTMENT OF HEALTH","source_url":"https://reporter.nih.gov/quickSearch/U18FD006418"},{"project":"U18FD006418","title":"Mississippi State Department of Health , MFRPS, and RRT Flexible Funding Model Maintenance Grant Application","fiscal_year":2021,"amount_usd":146591,"organization":"MISSISSIPPI STATE DEPARTMENT OF HEALTH","source_url":"https://reporter.nih.gov/quickSearch/U18FD006418"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"M.D., University of Arkansas for Medical Sciences (1978)","source_url":"https://www.cancer.columbia.edu/profile/susan-e-bates-md","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Editor-in-Chief, The Oncologist (2022)","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9256019","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Nir Uriel","slug":"nir-uriel","institution":"NewYork-Presbyterian","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/nir-uriel","json_url":"https://www.findmykol.com/kol/nir-uriel/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":11,"payments":2,"funding":57}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}